Omnicell, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| OC9.F | OMDA | TDOC | PHR | 2192.HK | NRC | |
|---|---|---|---|---|---|---|
| Market cap | 1.58B | 1.19B | 1.77B | 818.10M | 4.90B | 574.47M |
| P/E (TTM) | 41.7 | 81.0 | — | 77.5 | 12.7 | 100.3 |
| Forward P/E | 8.4 | 34.9 | -15.4 | 8.2 | 10.5 | 25.5 |
| Price/book | 1.4 | 4.7 | 1.4 | 2.2 | 0.9 | -63.0 |
| Dividend yield | — | — | — | — | 4.67% | 2.36% |
| 1-year change | +6.71% | −11.16% | +27.30% | −40.82% | −36.58% | +88.77% |
| Today | +11.61% | +4.57% | +9.11% | +7.77% | +2.24% | +12.46% |
The closest companies by business and industry (Health Information Services). Prices may be delayed up to 15 min.
Latest news
All OC9.F news ›Omnicell anticipates $1.225B-$1.231B 2026 revenue while raising non-GAAP EBITDA to $187M-$193M
Omnicell Q3 2026 earnings: revenue beat, raised profit outlook, Titan XT shipments near, and pipeline grew despite timing risks. Earnings Call Insights: Omnicell (OMCL) Q3 2026 - "In the third quarter 2026, we delivered another quarter of…
Omnicell Announces Third Quarter 2026 Financial Results
Omnicell (OMCL) delivers solid third quarter 2026 financial results Updates full year 2026 guidance FORT WORTH, Texas--(BUSINESS WIRE)-- Omnicell, Inc. (“Omnicell,” “we,” “our,” or the “Company”), a healthcare technology leader focused on…
More from 1 other outlet
Omnicell, Inc. (OMCL) Q3 2026 Earnings Call Transcript
Omnicell, Inc. (OMCL) Q3 2026 Earnings Call October 29, 2026 8:30 AM EDT David Unger - Vice President of Investor RelationsRandall Lipps - Founder, Executive Chairman & CEONnamdi Njoku - President & COOBaird Radford Stanislav Berenshteyn -…
Tranche Update on Omnicell, Inc.'s Equity Buyback Plan announced on May 22, 2025.
From April 1, 2026 to June 30, 2026, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 2,428,997 shares, representing 5.22%... Published on 08/05/2026 at 04:09 pm…
Tracelink, Inc. and Omnicell, Inc. Integrate Dscsa Compliance Solution into Hospital Pharmacy Operations
TraceLink, Inc. announced an integration between its Drug Supply Chain Security Act compliance solution and the pharmacy inventory management systems of Omnicell, Inc. This integration is expected to... announced an integration between its…
Omnicell, Inc.: Relative Strength Chart - Stock Nasdaq
Compare Omnicell, Inc. with the company of your choice via a Relative Strength chart. Real-time OMCL price, Nasdaq stock exchange Relative Strength Chart Omnicell, Inc. Advanced Medical Equipment & Technology All financial news and data…
Omnicell, Inc. (OMCL) – What Are Investment Firms Thinking About This Stock?
Shares of Omnicell, Inc. (NASDAQ:OMCL – Get Free Report) have earned an average rating of “Moderate Buy” from the nine analysts that are currently covering the firm, MarketBeat.com reports. Two equities research analysts have rated the…
Is This the Right Time to Retain Omnicell Stock in Your Portfolio?
Over the past year, this Zacks Rank #3 (Hold) stock has risen 24.2% against the 5.8% fall of the industry and the 18.6% growth of the S&P 500 composite. The renowned healthcare technology company has a market capitalization of $1.63…
Pharmacy Automation Market Is Going to Boom |• McKesson Corporation • Cardinal Health • Omnicell
openPR.com Pharmacy Automation Market Is Going to Boom |• McKesson Corporation • Cardinal Health • Omnicell Press release from: WMR Permanent link to this press release: You can edit or delete your pr
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- marketscreener.com9
- seekingalpha.com4
- prnewswire.com2
- stocktitan.net2
- fool.com1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 22 articles, not a forecast.